Longevity Health Holdings is registering 44,382 common shares tied to a $416,667 10% senior secured convertible note due February 29, 2028. The financing creates a direct obligation, is backed by Collateral and Subsidiary guarantees, and can result in additional common stock through conversion.
Key Highlights
- The note carries a 10% rate and matures on February 29, 2028.
- Warrants issued on January 2, 2025 will have their exercise price reduced to $1.38, while issuable shares rise to 712,307.
- Elevai Skincare, Carmell Regen Med and Carmell Cosmetics are providing subsidiary guarantees to Puritan Partners.
Longevity Health Holdings, Inc. (OTC: XAGE) is registering 44,382 common shares connected with a $416,667 senior secured convertible note issued to Puritan Partners LLC. The note carries a 10% rate and is due February 29, 2028, creating a direct financial obligation for the company.
$416,667 Note Backed
by Collateral The transaction documents are dated August 31, 2026, and identify Puritan Partners LLC as the purchaser and collateral agent. Security arrangements include an amended and restated security agreement and a separate intellectual property security agreement covering the company and its subsidiaries. Elevai Skincare, Inc. Carmell Regen Med Corporation and Carmell Cosmetics Corporation have guaranteed the obligations in favor of Puritan Partners. Longevity Health Holdings said proceeds from the notes are intended for working capital, subject to the settlement agreement dated August 13, 2026, involving Puritan Partners, the company and Carmell Regen Med Corporation. Shares issuable on exercise will increase from 292,929 to 712,307. Either party may terminate the purchase agreement if closing has not occurred by September 15, 2026.
FAQs
Q: What is Longevity Health Holdings registering?
A: Longevity Health Holdings is registering 44,382 common shares connected with a $416,667 senior secured convertible note issued to Puritan Partners LLC.
Q: What are the terms of the XAGE convertible note?
A: The note carries a 10% rate, matures on February 29, 2028, and creates a direct financial obligation secured through collateral arrangements.
Q: How are Longevity Health Holdings warrants changing?
A: Warrants issued on January 2, 2025 will have their exercise price reduced to $1.38. Shares issuable upon exercise will increase to 712,307.
Download Free Report – Explore 3 Stock Ideas & Industry Insights
Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.
All investments involve risk—consider independent advice before making any investment decisions.
View 3 Research Reports
Disclaimer:
Kalkine Equities LLC, with Delaware File Number 4697384, Foreign Qualification Registration in California File Number 202109211078, and Texas File Number 805521396, is authorized to provide general advice only. The information on https://kalkine.com/ does not take into account any of your investment objectives, financial situation or needs. You should consider the appropriateness of advice taking into account your own objectives, financial situation and needs and seek independent financial advice before making any financial decisions. The link to our Terms and Conditions and Privacy Policy has been provided for your reference. On the date of publishing the reports (mentioned on the website), employees and/or associates of Kalkine do not hold positions in any of the stocks covered on the website. These stocks can change any time and readers of the reports should not consider these stocks as advice or recommendations later.